FDA accepts submission for Hungarian pharmaceutical company Richter denosumab biosimilar

Hungarian pharmaceutical company Gedeon Richter and UK-based peer Hikma on Thursday announced that the United States Food and Drug Administration (FDA) accepted an application for Richter’s denosumab biosimilar candidate.

#pharmacy #health #Richter